Latest California Healthline Stories
How Mis- And Disinformation Campaigns Online Kneecap Coronavirus Response
The pandemic has been marked by a significant amount of misinformation — some spread on purpose — that could prove deadly.
As Problems Grow With Abbott’s Fast COVID Test, FDA Standards Are Under Fire
After the FDA issues a public warning about the test, one of its senior officials says point-of-care coronavirus tests can miss 20% of cases and still be considered useful. Public health experts are split.
Easy To Say ‘Get Tested.’ Harder To Do. Here’s How.
If you’ve been in a crowd — a protest or rally — experts have advice for figuring out whether you might have been exposed to the coronavirus, and where and when to get tested for it.
KHN’s ‘What The Health?’: SCOTUS, Trump Collide Over Transgender Rights
The Trump administration rolled back protections for transgender patients just days before the Supreme Court cemented LGBTQ rights under the Civil Rights Act. So, what now? Meanwhile, coronavirus politics reaches beyond health care settings. Anna Edney of Bloomberg News, Tami Luhby of CNN and Shefali Luthra of KHN join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
Hype Collides With Science As FDA Tries To Rein In ‘Wild West’ of COVID Blood Tests
Amid questions about the accuracy of the COVID-19 antibody tests flooding the market — and the usefulness of the results they provide — the FDA has belatedly stepped in to try to rein in the chaos.
Coronavirus Antibody Tests Are Sowing Confusion, Not Solutions
Some communities considered community antibody testing as a way out of lockdown. But they’ve pulled back as they realized antibody testing is the Wild West in an oversight vacuum.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Abbott’s Fast COVID Test Poses Safety Issues, Lab Workers Say
HHS said this test would “save personal protective equipment.” But Abbott’s very design ― devised for mobile testing — means those working with specimens need even more protection, experts warn.
Amid Pandemic, FDA Seizes Cheaper Drugs From Canada
Many Americans order drugs from Canada and other countries because they are cheaper, but U.S. authorities appear to be cracking down on the practice.